Jiesen tries to take over the world

[jiesen]

bought LJPC at 2.1

yes, I agree! Which is why I just picked up another 1% today at 2.1.

I'm still holding on to another 1% cash to put here, for later...

[Websman]

I just picked up a position in LJPC at 1.98.

Let's make some money!

[jiesen]

yep, all signs are a go on this one- 600+ patients are now in the trial (out of 700 or so needed), the site update out this week shows an increase from 120 to 150 sites running the study, and at the same time, Al Gonzales bought another 0.5M shares. My money is on a successful trial, and I think the rewards will be HUGE if indeed it happens like I predict. I was actually just over at LJP today, (a former coworker owes me some girl scout cookies) and they're still plugging along, doing their thing.

[stojakapimp]

yep, all signs are a go on this one- 600+ patients are now in the trial (out of 700 or so needed), the site update out this week shows an increase from 120 to 150 sites running the study, and at the same time, Al Gonzales bought another 0.5M shares. My money is on a successful trial, and I think the rewards will be HUGE if indeed it happens like I predict. I was actually just over at LJP today, (a former coworker owes me some girl scout cookies) and they're still plugging along, doing their thing.

So I take it you live in San Diego? I work right in La Jolla by Scripps.

[jiesen]

yep, I live in Clairemont just off the 805. I go running in your neck of the woods all the time.

[IIC]

So I take it you live in San Diego? I work right in La Jolla by Scripps.

Well...Everyone knows that the BEST traders are in California...I'm in West LA between Culver City and Westwood

[Websman]

LJPC dropped .23 today??? Now it's up .19 AH???

This is not logical....

[jiesen]

LJPC is going the wrong way...

It might have something to do with the general market turmoil combined with the "going concern" news out today- but I think of it as just one last opportunity for me to get a few more shares before the panic subsides and logic once again rules the market. I'll be looking to buy again (about a 1 or 2% stake) tomorrow, or later this week.

[jiesen]

Bought LJPC at 1.77

Ok, made my last purchase today of LJPC- 1.77 for a 2% position. I don't think it'll go any lower than this, unless it's really a goner.

[peanuts]

Ok, made my last purchase today of LJPC- 1.77 for a 2% position. I don't think it'll go any lower than this, unless it's really a goner.

dude... this stock SUX! I bought it at $2 just because you've been pumping it for so long.... I'll let time tell whether I should slap ya on the back or in the face I'm riding it until it doubles or goes under

[Websman]

dude... this stock SUX! I bought it at $2 just because you've been pumping it for so long.... I'll let time tell whether I should slap ya on the back or in the face I'm riding it until it doubles or goes under

The selling looks to have subsided today. We go up from here...I hope. If this thing gets good news and shoots up to $50, I'm going to fly to California and personally shake Jiesen's hand. jejeje

[mrmarket]

Ok, made my last purchase today of LJPC- 1.77 for a 2% position. I don't think it'll go any lower than this, unless it's really a goner.

The fact that they are ramping up SGA is a good sign. They wouldn't waste their money unless something was brewing.

[skiracer]

dude... this stock SUX! I bought it at $2 just because you've been pumping it for so long.... I'll let time tell whether I should slap ya on the back or in the face I'm riding it until it doubles or goes under

dropped .05 in todays action. if it can't make a move up on a day like today seems to indicate not much accumulative interest.

[IIC]

They wouldn't waste their money unless something was brewing.

Happens all the time

[jiesen]

The selling looks to have subsided today. We go up from here...I hope. If this thing gets good news and shoots up to $50, I'm going to fly to California and personally shake Jiesen's hand. jejeje

Well, I would certainly prefer that scenario. It all really depends on the outcome of this trial, and I'm dying to hear the results. But as I've said before, they seem to have everything lined up right now for a successful trial-- more than double the patients, 9x the dose. The previous trial very nearly proved efficacy, and would have proved it had either of these two things not screwed it up: 1) placebo patients were dropping out of the trial midway and 2) the trial design was longer than it should have been. But with the increased power of the trial, additional steps taken to ensure patient compliance, and with the fact that an increased dose is shown definitively to more effectively reduce the level of harmful antibodies than the lower dose, it is much more likely that this trial will prove efficacy, in my opinion.

That said, there are still other challenges LJPC faces, especially with financing and logistics of the trial. When will the interim data (for the first 43 flares) be out? When will the enrollment be complete? (should be next quarter) Will the 3 major investors be willing to cough up the additional funds to complete the trial, given that it's a good 3-6 months behind schedule? And will the fact that they are holding $10M in illiquid bonds (news just out with the 10k yesterday) tank the share price so far that the next round of funding practically wipes the current investors out? Who knows, and that's what makes a horse race... But barring any major financial pinch or further delays in the trial, and if the drug is shown to work, I wouldn't say a $50 share price in a couple years is an unreasonable expectation.

And as far as promoting this stock goes... here's how I see it: One of two things can happen to kill the drug, Riquent. 1) It doesn't work, and the trial proves it. 2) It works, but the money is insufficient to bring this last trial to a successful conclusion. If #1 happens, then oh well, it's back to the drawing board, and the only thing lost is money. If #2 happens, then it's a crying shame for the lupus patients whose lives could have been improved/saved by a working drug which will go back on the development shelf, probably never to be seen again, and all for want of a mere pittance compared to what's been already invested into this research. So yeah, I have no problem promoting LJPC if doing so has any chance of preventing #2, even if it might end up costing you (and me) some money.

Yes, Doug, companies waste money all the time, and at the end of it LJPC may very well have nothing to show for all the money spent. But the work they are doing is anything but a waste.